PRO MEDICUS LIMITED — Director's Dealing 2010

Mar 2, 2010

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public. Introduced 30/9/2001.

Name of entity	Pro Medicus Limited
ABN	25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Peter Terence KEMPEN
Date of last notice	15 December 2009

Part 1 - Change of director's relevant interests in securitiesIn the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest	Ordinary fully paid shares in Pro Medicus
(including registered holder)	Limited held by the Elaine Kempen
Note: Provide details of the circumstances giving rise to the relevantinterest.	Superannuation Fund of which the Director
	is a Trustee and Member
Date of change	2 March 2010
No. of securities held prior to change	89,647
Class	Ordinary shares
Number acquired	40,000
Number disposed	Nil
Value/Consideration	70.0 cents per share for 40,000 shares
Note: If consideration is non-cash, provide details and estimated valuation
No. of securities held after change	129,647 ordinary shares

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 1

Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	On market purchase

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation	N/A
Interest after change	N/A

For and on behalf of Pro Medicus Limited

ft ff

Anthony Hall Executive Director 3 March 2010

+ See chapter 19 for defined terms.